In response to enquiries, New Zealand’s Optometrists and Dispensing Opticians Board (ODOB) has confirmed that using amniotic membranes (AM) for patient care is within an optometrists’ scope of
Ophthalmology New Zealand (ONZ) has launched a new Facebook site to educate and inform the general public about ophthalmology and eyecare in New Zealand.
2021 marks the 175th anniversary of the famous scientific optics company Zeiss, which has played a key role in the evolution of microscopy, ophthalmology and optometry, and even the 1969 Moon landing.
The ZEISS CT LUCIA 621P/PY is a new generation of aspheric, monofocal, hydrophobic C-loop intraocular lens (IOL) featuring the patented ZEISS Optic (ZO) asphericity concept, designed to provide exceptional vision for a broad variety of eyes. Due to its architecture, this fully preloaded IOL enables
A study comparing the benefits of slowing myopia progression by one diopter with the known treatment risks has found that the advantages of treatment outweigh the threats to vision.
The Australian Society of Ophthalmologists (ASO) has launched a campaign to alert Australians to the dangers of US-style managed healthcare and the potential consequences for insured
A large study of age-related macular degeneration (AMD) patients has found that lifestyle factors such as smoking and a diet including fresh vegetables and fish impact disease progression in those who
Apple’s latest operating system (OS) includes options to track walking steadiness, Covid-19 vaccine status and to share health data with a medical practitioner. Launched on 7 June 2021, Apple said
A Canadian analysis supports pneumatic retinopexy (PnR) as a superior retinal reattachment technique compared with pars plana vitrectomy (PPV), in achieving long-term integrity of photoreceptors.
Associate Professor Ilva Rupenthal, director of the Buchanan Ocular Therapeutics Unit at Auckland University, has been awarded the well-known international Humboldt Fellowship for Experienced Researchers, to help her tackle dry eye disease (DED).
French biopharma Gensight Biologics has published the first case report of gene therapy leading to the partial recovery of visual function in a blind patient with late-stage retinitis pigmentosa (RP).
Auckland-based health tech company Clanwilliam Health has developed Healthlink SecureIT Cloud to allow New Zealand’s health professionals to access the private Connected Health network from the cloud.